International Conference on Pharmacovigilance, Drug Safety and Efficacy
Pharmacovigilance, Drug Safety and Efficacy Conference aims to bring together leading academic scientists, researchers and research scholars to exchange and share their
experiences and research results on all aspects of Pharmacovigilance, Drug Safety and Efficacy Conference.
It also provides a premier interdisciplinary platform for researchers, practitioners, and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmacovigilance, Drug Safety and Efficacy Conference.
Upcoming Conferences
DIGITAL
April 2025 in Tokyo
- Conference Code: 25JPTO04ICPDSE002
- Abstract/Full-Text Paper Submission: January 15, 2025
- Notification of Acceptance/Rejection: January 31, 2025
- Final Paper and Early Bird Registration: March 22, 2025
- Conference Date: April 17-18, 2025
- Conference Program
DIGITAL
August 2025 in Montreal
- Conference Code: 25CAMO08ICPDSE002
- Abstract/Full-Text Paper Submission: January 15, 2025
- Notification of Acceptance/Rejection: January 31, 2025
- Final Paper and Early Bird Registration: July 05, 2025
- Conference Date: August 07-08, 2025
- Conference Program
HYBRID
April 2026 in Tokyo
- Conference Code: 26JPTO04ICPDSE002
- Abstract/Full-Text Paper Submission: February 13, 2025
- Notification of Acceptance/Rejection: February 27, 2025
- Final Paper and Early Bird Registration: March 22, 2026
- Conference Date: April 22-23, 2026
- Conference Program
HYBRID
August 2026 in Montreal
- Conference Code: 26CAMO08ICPDSE002
- Abstract/Full-Text Paper Submission: February 13, 2025
- Notification of Acceptance/Rejection: February 27, 2025
- Final Paper and Early Bird Registration: July 05, 2026
- Conference Date: August 05-06, 2026
- Conference Program